This week, trade negotiators from some of the world’s most powerful economies are meeting in Guam to thrash out the final stages of the Trans Pacific Partnership. This free trade agreement – which in Asia includes Singapore, Malaysia, Japan, Vietnam and Brunei – stands to become a significant milestone in the deeper integration of the global economy.
Despite the economic potential of the TPP, one of its cornerstones – stronger intellectual property rights – remains controversial; with health NGOs claiming it will impact public health by raising the price of medicines.
To what extent are such fears justified? Why is intellectual property in this trade agreement important for the future of medical innovation? And what does the TPP mean for health in the Asia region?
Please join Southeast Asia Network for Development (SEANET) and Geneva Network for a panel discussion on these important issues. Details as follows:
Date: Thursday, 21st May 2015-05-13
Time: 10:30 – 12:00pm
Venue: Bugis Vault III, Intercontinental Singapore
Dr Deborah Elms, Executive Director, Asian Trade Centre
Prof Elizabeth Siew Kuan Ng, Faculty of Law, National University of Singapore
Philip Stevens, Director, Geneva Network (United Kingdom)
Bill Claxton, President, Carcinoid & NeuroEndocrine Tumour Society (Singapore)
Andrew Spiegel, Global Colon Cancer Association (United States)
Representative from the pharmaceutical industry (TBC)
To RSVP, please email email@example.com
The Southeast Asia Network for Development (SEANET) is a regional centre that promotes ideas to make ASEAN’s growth more inclusive and sustainable. SEANET is a project of the Institute for Democracy and Economic Affairs (IDEAS), headquartered in Kuala Lumpur.
Geneva Network is a public policy research and advocacy organisation working at the nexus of international intellectual property, health and trade issues.